Big Data and Deep Scanning For Cancer and Other Disease Treatment

Big Data and Deep Scanning For Cancer and Other Disease Treatment
There is continuing to be an exponential rise in the various types of technology that continue to evolve in order to help treat problems in medicine that seemed insurmountable only a few years ago, ask Ben Landa and Bent Philipson. One of these is personalized and accurate care that can now be achieved through the use of big data in order to determine patterns for things like cancer, ALS, Alzheimer’s, and other deadly encounters. This level of technology uses a collaboration of everything from the large data set, artificial intelligence, and other bleeding edge algorithms for medicine.

Now there are digital pathway workflow solutions that companies are working together to help advance the treatments so that patients have a better chance at continuing their life and living free of the disease or illness like SentosaCare. For example, digital pathology is one of the increasing niches whereby slide scanners are used that are capable of high-fidelity as well as high-throughput scanning, and this helps to automate a process that for so many years has required the laborious attention of staff members.

The process with these scanners allows digitizing of these slides so that they can easily be imported into the big data databases that are so necessary to make any progress. After that, the images can be cataloged and stored as appropriate. Search algorithms of high complexity can then allow researchers to find exactly what they are looking for – such as similar specimens that come from a patient that has been experiencing the same symptoms and disease progression.

Inspirata is one such company that excels in this type of work, and now they are providing a Cancer Information Data Trust (CIDT) that holds all of this data so that administrators, biopharma scientists, patients, and researchers can all look through the relevant information in regards to cancer patient diagnoses and treatments with outcomes. Tumors, drugs, biomarkers, and pathways are all relevant categories that the company is now making easier for anyone in need to access as part of their workflow. Leica Biosystems is one of the top companies that provides these type of scanners for this work, and Inspirata has actually just signed off on an agreement that utilizes their suite of tools as part of their digital workflow solution. It is definitely a good time for everyone in the medicine arena to push for timely recognition of patterns not seen before so that these diseases can be conquered faster than once believed.

Leave a Reply

Your email address will not be published. Required fields are marked *